Titan Pharmaceuticals, Inc. (TTNP) Earnings History
Annual and quarterly earnings data from 1995 to 2024
Loading earnings history...
TTNP EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TTNP Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | 100.0% | -727700.0% | -556900.0% |
| 2022 | -226.7% | -17058.3% | -16961.7% |
| 2021 | 87.0% | -613.0% | -531.7% |
| 2020 | 90.2% | -151.9% | -428.4% |
Download Data
Export TTNP earnings history in CSV or JSON format
Free sign-in required to download data
Titan Pharmaceuticals, Inc. (TTNP) Earnings Overview
As of May 8, 2026, Titan Pharmaceuticals, Inc. (TTNP) reported trailing twelve-month net income of -$3M, reflecting +29.4% year-over-year growth. The company earned $-2.63 per diluted share over the past four quarters.
Looking at the long-term picture, TTNP's historical earnings data spans multiple years. The company achieved its highest annual net income of $10M in fiscal 2013.
Titan Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NKTR (-$164M net income, -297.1% margin), MTLS ($7M net income, 2.9% margin), ORMP (-$24M net income), TTNP has comparable earnings metrics. Compare TTNP vs NKTR →
TTNP Earnings vs Peers
Earnings metrics vs comparable public companies
TTNP Historical Earnings Data (1995–2024)
30 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$5M | +15.5% | -$5M | $-5.23 | - | - |
| 2023 | -$6M | +45.3% | -$7M | $-7.41 | -556900.0% | -727700.0% |
| 2022 | -$10M | -25.4% | -$10M | $-15.15 | -16961.7% | -17058.3% |
| 2021 | -$8M | +60.9% | -$9M | $-4.06 | -531.7% | -613.0% |
| 2020 | -$21M | -28.8% | -$7M | $-10.38 | -428.4% | -151.9% |
| 2019 | -$16M | -78.3% | -$17M | $-9.83 | -445.6% | -466.5% |
| 2018 | -$9M | +36.9% | -$8M | $-47.59 | -152.6% | -139.8% |
| 2017 | -$14M | -378.6% | -$15M | $-121.34 | -6654.4% | -6745.1% |
| 2016 | $5M | +145.5% | $4M | $36.01 | 34.1% | 28.8% |
| 2015 | -$11M | -369.4% | -$7M | $-101.24 | -675.0% | -404.5% |
See TTNP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TTNP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TTNP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTTNP — Frequently Asked Questions
Quick answers to the most common questions about buying TTNP stock.
Is TTNP growing earnings?
TTNP EPS is $-2.63, with earnings growth accelerating to +29.4%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-3M.
What are TTNP's profit margins?
Titan Pharmaceuticals, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are TTNP's earnings?
TTNP earnings data spans 1995-2024. The accelerating earnings trend is +29.4% YoY. Historical data enables comparison across business cycles.